By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Acceleron Pharma 

128 Sidney Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-649-9200 Fax: 617-649-9988


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Alkermes 





Company News
Acceleron Pharma Reports Second Quarter 2015 Financial And Operational Results 8/6/2015 12:13:33 PM
Acceleron Pharma Announces Publication In Cancer Research Demonstrating Dalantercept Prevents Metastases In Preclinical Studies Of Breast Cancer 6/15/2015 10:54:40 AM
Acceleron Pharma Announces New Luspatercept Phase 2 Clinical Results At The 20th Congress Of The European Hematology Association 6/12/2015 11:02:49 AM
Acceleron Pharma To Host Conference Call And Webcast To Review New Luspatercept Data Presented At The 20th Congress Of The European Hematology Association 6/9/2015 11:07:28 AM
Acceleron Pharma To Present At Upcoming Investor Conferences In June 5/27/2015 11:20:34 AM
Acceleron Pharma To Present Luspatercept Clinical Trials At The 20th Congress Of The European Hematology Association 5/22/2015 6:35:51 AM
Acceleron Pharma To Present Dalantercept Clinical Data At The 2015 ASCO Annual Meeting 5/14/2015 12:21:29 PM
Acceleron Pharma Reports First Quarter 2015 Financial And Operational Results 5/7/2015 12:52:27 PM
Acceleron Pharma Release: Luspatercept Data Presented At The 13th International Symposium On Myelodysplastic Syndromes 5/4/2015 10:30:19 AM
Celgene (CELG) And Acceleron Pharma Select Luspatercept To Advance To Phase 3 In Myelodysplastic Syndromes 4/30/2015 9:57:27 AM
12345678910...
//-->